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Hyperthermia Treatment of Experimental Tumors 
J. Denekamp, PhD,* S. A. Hill, PhD,* and F. A. Stewart, PhD* 
The therapeutic advantage of combining hyperthermia 
with x-irradiation to treat tumors depends on whether or 
not it is possible to achieve greater thermal sensitization of 
tumors than of normal tissues. To determine such therapeu-
tic gain factors (TGE), we assessed the response of mouse 
skin and seven transplantable mouse tumors to graded 
x-ray doses given alone or combined with moderate heat 
(42.5°C for 60 minutes). We constructed dose response 
curves for the average early skin reaction and for the 
induced delay in tumor regrowth to an arbitrarily chosen 
size. 
We studied the following areas: 1) the therapeutic gain of 
combining heat with x-irradiation; 2) irradiation and heat 
sequencing; 3) vascular occlusion; 4) temperature uni-
formity; 5) hyperthermia and metastatic spread; 6) frac-
tionated treatment; and 7) thermal tolerance. Our results 
are not as promising as those of other published studies. 
We have shown that the time interval between heat and 
irradiation is important, and we believe that the separate 
cytotoxic action of heat and x-irradiation is likely to be 
more beneficial than the synergistic effect of combining the 
two in close sequence. We have also demonstrated the 
deficiencies of using hot water to achieve uniform heating, 
and the possible artefacts of vascular occlusion. We ob-
served no significant effect on the spread of metastases 
when heat is used adjunctively with x-rays. We also in-
duced thermal tolerance in a mouse tumor, which may 
account for the loss of therapeutic advantage seen with 
fractionated treatments. 
T he usefulness of hyperthermia as an adjunct to ra-
diotherapy depends upon achieving a greater thermal sen-
sit izat ion of tumors than of normal tissues. Thus, 
quantitative studies of the thermal sensitization of both 
tumors and normal tissues treated under comparable con-
ditions are needed before the technique can be adopted for 
clinical use. 
Materials and Methods 
In order to determine therapeutic gain factors,* we as-
sessed the response of mouse skin and of seven transplant-
able mouse tumors to graded x-ray doses, given alone or 
combined with moderate heat (42.5°C for 60 minutes). We 
constructed dose response curves for the average early skin 
* Gray Laboratory, Mount Vernon Hospital, Northwood, Middlesex, 
England 
Address reprint requests to Dr. Denekamp, Gray Laboratory, Mt. Vernon 
Hospital, Northwood, Middlesex HA6 2RN, England 
reaction (scored between 10 and 32 days) and for the 
induced delay in tumor regrowth to an arbitrarily chosen 
size (4.5 mm larger diameter than at irradiation). 
The details of the experimental procedures have been 
published elsewhere (1-3). Briefly, the mice are anesthe-
tized wfth sodium pentobarbital, irradiated with 240 kV 
x-rays, and heated locally by immersing the foot or the 
tumor in a water bath maintained by a pump and ther-
mostat at the desired temperature. 
Several questions have been posed: 
1) Are tumors sensitized to x-rays more than skin if an 
equal heat treatment is applied to both? 
2) Is the sequence of heat and x-irradiation important? 
3) Are there experimental artefacts due to methods of 
restraint or the site of tumor implant? 
* Thermal Enhancement Ratio (TER) 
Therapeutic Cain Factor (TGF) 
x-ray dose without heat 
x-ray dose with heat 
TER tumor 
TER normal tissues 
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Fig.1 
Dose response curves for early skin reactions on mouse feet treated w i th 
x-rays alone or x-rays fol lowed immediately by heat for 60 minutes at 
42.5°C. Hatched areas represent envelopes drawn through the standard 
errors on the points; a significant TER is observed only in the clear space 
between the hatched areas. 
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Fig. 2 
Dose response curves for regrowth delay of the fibrosarcoma SA FA 
treated wi th x-rays alone or combined w i th heat. Less thermal sensitiza-
t ion is evident than in the skin (Fig. 1). 
4) How non-uniform is the heating of tissues with hot 
water? 
5) Does hyperthermia influence the incidence or time of 
appearance of metastases? 
6) Is the same therapeutic gain observed wfth single doses 
and with fractionated treatments? 
7) Is thermal tolerance induced in both skin and tumors? 
Results 
Therapeutic gain 
Fig. 1 shows the dose response curves for skin treated with 
x-rays alone or wfth x-rays followed by heating at 42.5°C 
for 60 minutes. We found that heat definitely enhanced the 
effect of radiation. Fig. 2 shows the response of a trans-
plantable mouse tumor treated in the same way. The 
amountof sensftization is significant but lessthan the effect 
observed in the skin. Sensitization does seem to vary with 
dose level and seems greatest at the higher levels. 
Table I shows the TER values measured at equivalent dose 
levels for skin and for seven different transplantable mouse 
tumors, when the beat is given wfthin minutes after irradia-
tion. The tumor TER values are similar to or less than those 
observed in skin, indicating no therapeutic gain relative to 
treatment with x-rays alone. Skin TER values are shown for 
heat treatments at temperatures of both 42.5°C and 41.5°C, 
because the tumor may have regions significantly cooler 
than skin for the same water bath temperature (see below). 
These tumor data are plotted in Fig. 3 for comparison with 
all similar data from the literature. Our tumor data (solid 
symbols) are plotted as if 0.3°C below the waterbath tem-
perature. The Gray Laboratory tumor data clearly give a 
more pessimistic picture than many other published tumor 
results, which may be artificially high because of inadver-
tent vascular occlusion (see below). 
Sequencing of irradiation and heat 
TER values have been measured for both skin and the seven 
types of transplantable tumor with intervals ranging from 
0-24 hours and with heat given either before or after 
irradiation (1,3). Fig. 4 shows the data for one tumor (SA FA) 
compared with the results for skin heated at 42.5°C for one 
hour. The thermal sensitization of skin (solid line) is rapidly 
lost as the intervals increase, particularly when the heat 
follows irradiation, but an effect is still observed in the 
tumor at six hours. Thus, although the absolute thermal 
sensitization of tumors is greatest with consecutive treat-
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TABLE I 
Thermal Enhancement and Therapeutic Gain for X-rays and Heat 
TER TGF* TGF** 
skin 
42.5°C 1.7-1.8 
— — 
41.5°C 1.5 
— — 
t umors 
SA.FA 1.5-1.7 0.9 1.1 
CA.SQ.D 1.5-1.7 0.9 1.1 
GA.NTa 1.2-1.4 0.7 0.9 
SA.S 1.1-1.3 0.7 0-8 
SA.F 1.2-1.4 0.7 0.9 
GA.MT 1.5-1.7 0.9 1.1 
CA.RH 1.0-1.3 0.6 0.8 
' TGF values calculated relative to the skin heated to 42.5°C. 
' TGF values calculated relative to the skin heated to 41.5°C. 
ments, a therapeutic advantage is seen only with the longer 
intervals. For consecutive heat and irradiation, there is 
often a therapeutic loss, whereas for heat before irradiation 
the response of both skin and tumor is more unpredictable, 
showing sensitization at some intervals and not at others (4). 
Table II shows the TGF for six tumors compared with skin 
for the different time intervals tested. Because the sensftiz-
ing effect on skin diminishes with time, atl interval between 
x-rays and heat of three to six hours has the advantage that 
no reduction in radiation dose is needed to prevent exces-
sive injury to normal tissue. For shorter intervals the radia-
tion dose would have to be reduced to stay within the limits 
of normal tissue tolerance. This separation of x-rays and 
heat probably utilizes the independent cytotoxic action of 
the two agents rather than their synergistic interaction. 
Results consistent with ours have been reported for normal 
tissues by the Hammersmith group (5) and for tumors by 
Jansen, et al (6) and by Overgaard (7). 
Vascular occlusion 
Hypoxia, nutrient deficiency, and low pH are all factors 
known to influence the sensitivity to direct heat killing. We 
have shown that occluding the blood supply wfth a clamp 
can result in tumor cures wfth immersion at 44.8°C for 15 
minutes, whereas no cures are achieved with this heat dose 
in unobstructed tumors (8). These results of two different 
types of tumor (previously unpublished for SA F) are shown 
in Figs. 5 and 6 (9). The fact that prolonged clamping is 
necessary to achieve the full effect suggests that neither 
hypoxia nor the loss of the cooling effect of flowing blood 
are major factors, as both ofthese would occur very rapidly 
after vascular occlusion. 
If a clamp is applied for a heat treatment of 42.8°C for one 
TABLE II 
Thermal Enhancement Ratios with Different Intervals Between 
Heat and X-rays 
Hours 
Heat -I- X-ray 
24 6 3 2 1 0 
Skin — 1.2 1.2 1.3 1.4 1.7 
SA FA — 1.0 1.8 1.3 1.1 1.4 
GASQD 1.3 1.4 1.4 1.6 1.3 1.7 
CANTa 1.2 1.2 1.2 — 1.3 1.3 
CAMT 0.9 — — — — — 
SAF 1.3 — — — — — 
SAS 1.0 — — — 1.3 — 
x-ray -i- Heat 
1 2 3 6 24 
1.8 1.3 1.2 1.0 1.0 — 
1.7 1.3 1.4 1.3 1.2 — 
1.6 1.3 1.5 1.2 1.2 1.2 
1.3 1.4 — 1.3 1.3 1.2 
1.6 1.5 1.8 1.5 1.1 
1.3 1.4 — 1.4 1.3 1.3 
1.2 1.3 — 1.0 1.1 1.0 
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Fig. 3 
Thermal enhancement ratio (TER) for consecutive x-rays and heat to skin 
(hatched area) and to tumors reported in the literature (see key) or from 
the Gray Laboratory. Much less sensitization is seen in our tumors than in 
many published studies. There is no therapeutic gain. 
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Fig. 4 
Thermal Enhancement Ratio (TER) for skin and for fibrosarcoma SA FA as 
a function of the sequence and intervals between x-rays and heat. 
hour combined with graded x-ray doses, thermal sensitiza-
tion is much greater than in undamped tumors. Similarly 
high TER values occurred for regrowth delay of undamped 
tumors when they were implanted subcutaneously on the 
tail. While the tail is a popular site for hyperthermia 
experiments because it is easy to heat without raising the 
body core temperature, the extreme constriction imposed 
by the skin on the tail may also act as a natural means of 
vascular occlusion (10). When TER values from clamped 
tumors or from tumors growing on the tail are compared 
with those in Fig. 3, they are among the higher values 
recorded in some other published studies (10). Ifthese latter 
TER values result from inadvertent vascular occlusion, they 
wil l not be relevant to most human tumors. Deliberate 
vascular occlusion is not likely to be useful for clinical 
therapy because it has been observed that the effectiveness 
of heat is also increased in normal tissues if the blood 
supply is occluded (11). 
Temperature uniformity 
Our initial studies were published on the basis that tumors 
achieved a temperature 0.3°C below water bath tempera-
ture, within three to five minutes of immersion. This state-
ment was based on readings with a Bailey 29G needle 
thermocouple in two tumor types, with the probe placed at 
various depths in each tumor. Although we observed very 
little variability, subsequent measurements on a larger 
number of tumors of varying histological types have failed 
to confirm this early observation. As others have reported 
(12), there are considerable temperature gradients across 
tumors and considerable variation from one tumor to an-
other, even within the same histological type. Fig. 7 shows 
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Fig. 5 
Tumor control for heat treatment applied at various times relative to an 
80-miniite period during which the blood supply is occluded (8). 
the probe measurements on many samples of four different 
types of tumor, with readings taken simultaneously with 
three probes at dif ferent posit ions w i th in each tumor 
(5.5-6.5 mm diameter). The temperature near the skin 
surface sometimes reaches 0.3-0.1 °C below the water tem-
perature, but at deeper levels adjacent to the underlying 
muscle much lower temperatures are recorded. A similar 
variation in temperature in relation to the main blood 
vessels has been reported for normal tissue fthe intestine) 
by Hume, et al (13). 
Our observations of temperature non-uniformity prompted 
us to attempt to quantitate thermal damage at different 
positions in the tumor by histological assessment of tumors 
30 
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Fig. 6 
Regrowth delay for heat treatment applied relative to the t ime of 
clamping. Increased delay is seen in clamped tumors (9). 
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Fig. 7 
Thermocouple determinations of the temperature at various positions 
within mouse tumors of four different types. There is a wide variation in 
the measured values, both between tumors and at different points within 
each one (9). 
obtained at sequential intervals after heating for one hour at 
42.8°C or 44.8°C (10). The results for one type of tumor are 
shown in Fig. 8. Dead cells were apparent within 24 hours 
of heating. At the lower temperature the pattern was not 
clear, with pyknotic and viable cells being seen at all 
positions across the tumor diameter. At the higher tempera-
ture (44.8°C), only a few viable ceils were seen in the 
tumor, most of them as a thin rim adjacent to the underly-
ing muscle. On successive days we observed that this rim 
expanded as the thermally protected cells proliferated. 
Thus, it is clear that water bath heating is inadequate as a 
means of elevating the temperature, even through 5-6 mm 
of tissue. For tumors, the crftical temperature wil l be in the 
cold spots, since these wil l resuft in surviving tumor foci 
from which the tumor can grow again. Such foci may occur 
adjacent to a heat sink (as in the subcutaneous muscle), or 
more locally around large blood vessels, where the heat 
can be dissipated by blood flow. In normal tissues, by 
contrast, the crftical temperatures wil l be those in the hot 
spots, since even a tenth of a degree can transform an 
acceptable normal tissue response into necrosis (14). 
Metastases and hyperthermia 
We have attempted to study the effect of heat on metastatic 
spread in both retrospective and prospective studies. In the 
retrospective analysis of animals in regrowth delay studies, 
the analysis is complicated by the duration ofthe regrowth 
delay and hence the time available for latent metastases to 
grow to an observable size. Fig. 9 compares the percentage 
of animals wfth metastases that died within certain time 
intervals (because of a regrowing primary tumor or because 
of sickness due to metastases) to the percentage of animals 
treated with x-rays alone or with x-rays plus heat. The 
combined treatments have been separated into those given 
in close sequence and those given with an interval longer 
than one hour between the x-rays and heat. The tendency 
noted toward more metastases in the heat-treated groups 
than in those treated with x-rays alone is not significant. It 
may result from the more effective treatment ofthe primary 
tumor so that a longer time is available for latent metastases 
to appear. In the SA FA, metastases tended to occur earlier, 
although the same high proportion developed after x-rays 
orthe combined treatment. The results from five retrospec-
tive analyses of metastases are summarized in Table III (9). 
Fractionated treatments 
On the basis of our single dose data, we concluded that 
heat given three hours after irradiation was more likely to 
be beneficial than heat given immediately after x-rays. We 
extended this study to two and five daily fractions of x-rays, 
with heat (42.5°C/60 minutes) given immediately or three 
hours after each fraction. Dose response curves were ob-
tained for both skin and tumor (SA FA) as before (15). The 
results are summarized in Table IV. In the fractionated 
experiment, the therapeutic gain observed with single 
TABLE III 
Incidence of Metastases After 
X-rays Alone or X-rays plus Heat 
Tumor X-rays -i- Heat 
long 
interval consec 
X-rays 
alone 
Heat -1- X-rays 
long 
consec interval 
CA SQ D 29% 34% 28% 45% 34% 
CA NTa 78% 65% 68% 65% 78% 
SA F 94% 89% 84% — 78% 
CAMT 20% 68% 50% — 36% 
SAS 2 1 % 22% 15% — 15% 
None of these tumors shows a significant increase in the incidence of 
metastases after the combined treatment. 
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Histological assessment of the surviving cells and repopulating tumors 
after two different heat treatments (duration: 60 minutes). Each symbol 
represents a tumor. After the higher temperature, cells survived only 
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Incidence of metastases as a function of the time at which the animal was 
sacrifked because of local recurrence of a treated tumor or because of 
sickness due to metastases. No significant change in the incidence or 
time of appearance occurred for the different treatments. 
doses with an interval of three hours was completely lost. 
This pessimistic result needs to be tested in other tumor 
types and with intervals other than 24 hours between 
successive doses. Longer intervals are not possible in this 
rapidly growing f ibrosarcoma, but a 24-hour interval 
means that each heat treatment is given 21 hours before the 
next x-ray fraction as well as three hours after the last. The 
loss of therapeut ic advantage could result f rom heat-
induced thermal tolerance, reoxygenation and recruitment, 
or increased blood flow. 
Thermal tolerance 
Thermal tolerance has been demonstrated both in vitro and 
in vivo. Joshi, et al (16) showed that quite low heat treat-
ment (SSf'C) could induce a tolerance to subsequent ther-
mal cel l k i l l i ng . Law, et al (14) showed that thermal 
tolerance to direct heat damage was greater, and lasted 
longer, than tolerance to heat sensit ization of x-ray 
damage. If thermal tolerance could be induced in normal 
tissues but not in tumors, then the therapeutic gain of 
fractionated treatments would be expected to be much 
greater than that seen with single doses. Unfortunately, for 
the tumor and the normal tissue on which we have tested 
this idea, the reverse seems to be true, i.e., induced thermal 
tolerance in the fibrosarcoma is greater than in the skin. We 
used a priming temperature of 42.5°C, and pretreatments 
with four daily heat treatments, each lasting 60 minutes, or 
a single heat treatment were followed 24 hours later by 
graded x-ray doses and heating at 42.5°C for 60 minutes 
(Table V). The thermal sensitization produced in the fibro-
sarcoma by x-rays and heat given in close sequence (TER = 
1.4) was completely lost if the tumor was preheated with 
either one or four doses of heat. Thus, thermal tolerance 
was readily induced in this tumor, a result which could 
explain the loss of therapeutic gain with fractionated treat-
ments. By contrast, the thermal sensitization of skin was the 
same (TER = 1.6) whether it was preheated or not, so that 
no induced thermal tolerance was observed. 
TABLE IV 
Thermal Enhancement and Therapeutic Gain 
with Fractionated Treatments 
Tumor TER Skin TER TGF 
Heat given immediately 
after each fraction 
Single doses 
2F/24 hrs 
5F/4 days 
Heat given three hours 
after each fraction 
Single doses 
2F/24 hrs 
5F/4 days 
1.5-1.7 
1.0 
1.1-1.3 
1.2-1.5 
1.0-1.1 
1.0-1.3 
1.7-1.8 
1.9 
1.7 
1.0 
1.1 
1.0-1.1 
0.8-1.0 
0.5 
0.6-0.8 
1.2-1.5 
0.9-1.0 
0.9-1.3 
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T A B L E V 
Thermal Tolerance in Skin and Tumor (SA FA) 
TER TER TGF 
tumor skin 
No preheating 1.4 1.6 0.9 
1 pretreatment 
(42.5°C/1 hr) 0.9 1.6 0.6 
4 pretreatments 
(each 42.5°G/1 hr) 1.0 1.6 0.6 
is likely to be more beneficial than the synergistic effect of 
combining the two in close sequence. We have also dem-
onstrated the deficiencies of using hot water to achieve 
uniform heating, and the possible artefacts of vascular 
occlusion. We observed no significant effect on the spread 
p f metastases when heat was used adjunctively with x-rays, 
although the metastases may appear earlier. We also in-
duced thermal tolerance in a mouse tumor, but not in 
mouse skin, which may account for the loss of therapeutic 
advantage seen with fractionated treatments. 
Summary 
The results using water bath heat combined with 240 kV 
x-rays to look at the therapeutic benefit of the combined 
modality are not as promising in our seven transplantable 
mouse tumors relative to skin as in many of the previously 
published studies. We have shown that the time interval 
between heat and irradiation is important, and we believe 
that the separate cytotoxic action of heat and x-irradiation 
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